Skip to main content
Top
Published in: Rheumatology International 10/2009

01-08-2009 | Original Article

Inflammatory response in patients with active and inactive osteoarthritis

Authors: Antoaneta Toncheva, Mimi Remichkova, Krassimira Ikonomova, Petya Dimitrova, Nina Ivanovska

Published in: Rheumatology International | Issue 10/2009

Login to get access

Abstract

In the present study, we have investigated comparatively the inflammatory response of patients with active and inactive osteoarthritis. The sera from 31 healthy individuals, 37 patients with active OA, and 19 patients with inactive OA were assayed for TNF-α, IL-6, sRANKL, RANTES, and MRP8 using ELISA in order to evaluate their potential as markers of disease activity. Also, the spontaneous and LSP-induced release of TNF-α and IL-6 by peripheral blood neutrophils was determined. The activation of OA is associated with elevated TNF-α, IL-6, and RANTES serum levels while sRANKL and MRP8 appeared to be increased in both active and inactive OA. The neutrophil spontaneous and up-regulated by LPS cytokine release can contribute to the exacerbation of OA.
Literature
3.
4.
go back to reference Hussein MR, Fathi NA, El-Din AM et al (2008) Alterations of the CD4(+), CD8 (+) T cell subsets, Interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathol Oncol Res 14:321–328PubMedCrossRef Hussein MR, Fathi NA, El-Din AM et al (2008) Alterations of the CD4(+), CD8 (+) T cell subsets, Interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathol Oncol Res 14:321–328PubMedCrossRef
5.
go back to reference Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE (2006) The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 8:R187. doi:10.1186/ar2099 PubMedCrossRef Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE (2006) The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 8:R187. doi:10.​1186/​ar2099 PubMedCrossRef
7.
go back to reference Iannone F, Lapadula G (2003) The pathophysiology of osteoarthritis. Aging Clin Exp Res 15:364–372PubMed Iannone F, Lapadula G (2003) The pathophysiology of osteoarthritis. Aging Clin Exp Res 15:364–372PubMed
8.
go back to reference Abbas H, Ambrosius W, Nicklas BJ et al (2004) Inflammatory markers and physical function among older adults with knee osteoarthritis. J Rheumatol 31:2027–2031PubMed Abbas H, Ambrosius W, Nicklas BJ et al (2004) Inflammatory markers and physical function among older adults with knee osteoarthritis. J Rheumatol 31:2027–2031PubMed
12.
go back to reference de Hooge AS, van De Loo FA, Arntz OJ, van Den Berg WB (2000) Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis. Am J Pathol 157:2081–2091PubMed de Hooge AS, van De Loo FA, Arntz OJ, van Den Berg WB (2000) Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis. Am J Pathol 157:2081–2091PubMed
14.
go back to reference Takayanagi H, Ogasawara K, Hida S et al (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408:600–605. doi:10.1038/35046102 PubMedCrossRef Takayanagi H, Ogasawara K, Hida S et al (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408:600–605. doi:10.​1038/​35046102 PubMedCrossRef
15.
go back to reference Crotti TN, Smith MD, Weedon H et al (2002) Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis 61:1047–1054. doi:10.1136/ard.61.12.1047 PubMedCrossRef Crotti TN, Smith MD, Weedon H et al (2002) Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis 61:1047–1054. doi:10.​1136/​ard.​61.​12.​1047 PubMedCrossRef
16.
go back to reference Skoumal M, Kolarz G, Haberhauer G et al (2005) Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis. Rheumatol Int 26:63–69. doi:10.1007/s00296-004-0579-1 PubMedCrossRef Skoumal M, Kolarz G, Haberhauer G et al (2005) Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis. Rheumatol Int 26:63–69. doi:10.​1007/​s00296-004-0579-1 PubMedCrossRef
18.
go back to reference Boiardi L, Macchioni P, Meliconi R et al (1999) Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol 17:419–425PubMed Boiardi L, Macchioni P, Meliconi R et al (1999) Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol 17:419–425PubMed
19.
go back to reference Stanczyk J, Kowalski ML, Grzegorczyk J et al (2005) RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Mediators Inflamm 2005:343–348. doi:10.1155/MI.2005.343 PubMedCrossRef Stanczyk J, Kowalski ML, Grzegorczyk J et al (2005) RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Mediators Inflamm 2005:343–348. doi:10.​1155/​MI.​2005.​343 PubMedCrossRef
21.
go back to reference Rammes A, Roth J, Goebeler M et al (1997) Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 272:9496–9502. doi:10.1074/jbc.272.14.9496 PubMedCrossRef Rammes A, Roth J, Goebeler M et al (1997) Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 272:9496–9502. doi:10.​1074/​jbc.​272.​14.​9496 PubMedCrossRef
23.
go back to reference Wipke BT, Allen PM (2001) Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 167:1601–1608PubMed Wipke BT, Allen PM (2001) Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 167:1601–1608PubMed
27.
go back to reference Pilichou A, Papassotiriou I, Michalakakou K et al (2008) High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappaB ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. Clin Biochem 41:746–749. doi:10.1016/j.clinbiochem.2008.02.011 PubMedCrossRef Pilichou A, Papassotiriou I, Michalakakou K et al (2008) High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappaB ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. Clin Biochem 41:746–749. doi:10.​1016/​j.​clinbiochem.​2008.​02.​011 PubMedCrossRef
29.
go back to reference Youssef P, Roth J, Frosch M et al (1999) Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol 26:2523–2528PubMed Youssef P, Roth J, Frosch M et al (1999) Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol 26:2523–2528PubMed
31.
go back to reference Brun JG, Jonsson R, Haga HJ (1994) Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 21:733–738PubMed Brun JG, Jonsson R, Haga HJ (1994) Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 21:733–738PubMed
32.
34.
go back to reference Drynda S, Ringel B, Kekow M et al (2004) Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol Res Pract 200:165–171. doi:10.1016/j.prp.2004.02.011 PubMedCrossRef Drynda S, Ringel B, Kekow M et al (2004) Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol Res Pract 200:165–171. doi:10.​1016/​j.​prp.​2004.​02.​011 PubMedCrossRef
35.
Metadata
Title
Inflammatory response in patients with active and inactive osteoarthritis
Authors
Antoaneta Toncheva
Mimi Remichkova
Krassimira Ikonomova
Petya Dimitrova
Nina Ivanovska
Publication date
01-08-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-0864-0

Other articles of this Issue 10/2009

Rheumatology International 10/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.